Literature DB >> 30485241

Intramedullary spinal cord ependymoma and astrocytoma: intraoperative frozen-section diagnosis, extent of resection, and outcomes.

Hiroki Hongo1, Keisuke Takai1, Takashi Komori2, Makoto Taniguchi1.   

Abstract

OBJECTIVEThe intraoperative differentiation of ependymomas from astrocytomas is important because neurosurgical strategies differ between these two tumor groups. Previous studies have reported that the diagnostic accuracy of intraoperative frozen sections of intracranial central nervous system (CNS) tumors is higher than 83%-97%, whereas that for spinal intramedullary tumors remains unknown. Herein, authors tested the hypothesis that intraoperative frozen-section diagnosis is the gold standard for a differential diagnosis of intramedullary spinal cord tumors.METHODSThe clinical characteristics, intraoperative histological diagnosis from frozen sections, extent of tumor resection, progression-free survival (PFS), and overall survival (OS) of 49 cases of intramedullary spinal cord ependymomas (n = 32) and astrocytomas (n = 17) were retrospectively evaluated.RESULTSThe frozen-section diagnosis and final diagnosis with permanent sections agreed in 23 (72%) of 32 cases of ependymoma. Of the 9 cases of ependymoma in which the frozen-section diagnosis disagreed with the final diagnosis, 4 were incorrectly diagnosed as astrocytoma and the other 5 cases had a nonspecific diagnosis, such as glioma. Nonetheless, gross-total resection was achieved in 6 of these 9 cases given the presence of a dissection plane. The frozen-section diagnosis and final diagnosis agreed in 12 (71%) of 17 cases of astrocytoma. Of the 5 cases of astrocytoma in which the frozen-section diagnosis disagreed with the final diagnosis, 1 was incorrectly diagnosed as ependymoma and the other 4 had a nonspecific diagnosis. Gross-total resection was achieved in only 1 of these 5 cases.A relationship between the size of tumor specimens and the diagnostic accuracy of frozen sections was not observed. Ependymal rosettes and perivascular pseudorosettes were observed in 30% and 57% of ependymomas, respectively, but were absent in astrocytomas.Progression-free survival and OS were both significantly longer in cases of ependymoma than in cases of astrocytoma (p < 0.001). Gross-total resection was achieved in 69% of ependymomas and was associated with longer PFS (p = 0.041). In the astrocytoma group, gross-total resection was achieved in only 12% and there was no relationship between extent of resection and OS. Tumor grades tended to correlate with OS in astrocytomas (p = 0.079).CONCLUSIONSThe diagnostic accuracy of intraoperative frozen sections was lower for intramedullary spinal cord ependymomas and astrocytomas in the present study than that for intracranial CNS tumors reported on in the literature. Surgical strategies need to be selected based on multiple factors, such as clinical characteristics, preoperative imaging, frozen-section diagnosis, and intraoperative findings of the tumor plane.

Entities:  

Keywords:  CNS = central nervous system; GTR = gross-total resection; ISCT = intramedullary spinal cord tumor; OS = overall survival; PFS = progression-free survival; PR = partial resection; STR = subtotal resection; chemotherapy; histopathology; intramedullary tumor; oncology; overall survival; progression-free survival; radiation; surgical treatment; tumor grade

Mesh:

Year:  2018        PMID: 30485241     DOI: 10.3171/2018.7.SPINE18230

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  6 in total

1.  Clinical Prediction Modeling in Intramedullary Spinal Tumor Surgery.

Authors:  Elie Massaad; Yoon Ha; Ganesh M Shankar; John H Shin
Journal:  Acta Neurochir Suppl       Date:  2022

2.  Current Trends in the Surgical Management of Intramedullary Tumors: A Multicenter Study of 1,033 Patients by the Neurospinal Society of Japan.

Authors:  Toshiki Endo; Tomoo Inoue; Masaki Mizuno; Ryu Kurokawa; Kiyoshi Ito; Shigeo Ueda; Toshihiro Takami; Kazutoshi Hida; Minoru Hoshimaru
Journal:  Neurospine       Date:  2022-06-30

3.  Sodium Fluorescein for Spinal Intradural Tumors.

Authors:  Semih Kivanc Olguner; Ali Arslan; Vedat Açık; İsmail İstemen; Mehmet Can; Yurdal Gezercan; Ali İhsan Ökten
Journal:  Front Oncol       Date:  2021-01-28       Impact factor: 6.244

4.  Long-term Neurologic Outcome After Spinal Ependymoma Resection With Multimodal Intraoperative Electrophysiological Recording: Cohort Study and Review of the Literature.

Authors:  Grégoire P Chatain; Michael W Kortz; Stephanie Serva; Keshari Shrestha; Patrick Hosokawa; Timothy H Ung; Michael Finn
Journal:  Neurospine       Date:  2022-03-31

5.  Fluorescein-guided surgery for intradural spinal tumors: A single-center experience.

Authors:  Salvatore Massimiliano Cardali; Giuseppe Ricciardo; Giada Garufi; Giovanni Raffa; Francesco Messineo; Gianluca Scalia; Alfredo Conti; Antonino Germanò
Journal:  Brain Spine       Date:  2022-06-22

6.  Surgical treatment and neurological outcome of infiltrating intramedullary astrocytoma WHO II-IV: a multicenter retrospective case series.

Authors:  Vicki M Butenschoen; Vanessa Hubertus; Insa K Janssen; Julia Onken; Christoph Wipplinger; Klaus C Mende; Sven O Eicker; Victoria Kehl; Claudius Thomé; Peter Vajkoczy; Karl Schaller; Jens Gempt; Bernhard Meyer; Maria Wostrack
Journal:  J Neurooncol       Date:  2020-10-22       Impact factor: 4.130

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.